Publicaciones en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (13)

2022

  1. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169

  2. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  3. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  4. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

  5. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680

2015

  1. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150

2014

  1. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices

    BMC Microbiology, Vol. 14, Núm. 1

2009

  1. Escherichia coli producing SHV-type extended-spectrum β-lactamase is a significant cause of community-acquired infection

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 4, pp. 781-784

2008

  1. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli

    Archives of Internal Medicine, Vol. 168, Núm. 17, pp. 1897-1902

2003

  1. Antibiotic resistance and clinical significance of Haemophilus influenzae type f

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966